Keywords: Helsinn, CheilJedang, Netupitant, Palonosetron, South Korea, CINV

Helsinn out-licenses netupitant-palonosetron fixed dose combo in South Korea

Article | 25 September 2012

Print This

Privately-held Swiss company Helsinn Group says it has signed a license agreement with CJ CheilJedang of South Korea for Helsinn's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in